These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24301926)
1. Effect of inhibition of MEK pathway on 5-aza-deoxycytidine-suppressed pancreatic cancer cell proliferation. Wang X; Wang H; Jiang N; Lu W; Zhang XF; Fang JY Genet Mol Res; 2013 Nov; 12(4):5560-73. PubMed ID: 24301926 [TBL] [Abstract][Full Text] [Related]
2. Blockade of MEK signaling potentiates 5-Aza-2'-deoxycytidine-induced apoptosis and upregulation of p21(waf1) in acute myelogenous leukemia cells. Nishioka C; Ikezoe T; Yang J; Komatsu N; Koeffler HP; Yokoyama A Int J Cancer; 2009 Sep; 125(5):1168-76. PubMed ID: 19422044 [TBL] [Abstract][Full Text] [Related]
3. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. Pulukuri SM; Rao JS Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979 [TBL] [Abstract][Full Text] [Related]
4. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines]. Chen YX; Fang JY; Lu J; Qiu DK Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516 [TBL] [Abstract][Full Text] [Related]
5. Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2'-deoxycytidine. Deng T; Zhang Y Life Sci; 2009 Feb; 84(9-10):311-20. PubMed ID: 19159630 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. Gysin S; Lee SH; Dean NM; McMahon M Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment. Egger G; Aparicio AM; Escobar SG; Jones PA Cancer Res; 2007 Jan; 67(1):346-53. PubMed ID: 17210717 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463 [TBL] [Abstract][Full Text] [Related]
9. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713 [TBL] [Abstract][Full Text] [Related]
10. p21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation. Zheng QH; Ma LW; Zhu WG; Zhang ZY; Tong TJ J Cell Biochem; 2006 Aug; 98(5):1230-48. PubMed ID: 16514663 [TBL] [Abstract][Full Text] [Related]
11. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. Shin H; Kim JH; Lee YS; Lee YC Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241 [TBL] [Abstract][Full Text] [Related]
12. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway. Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122 [TBL] [Abstract][Full Text] [Related]
13. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells. Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784 [TBL] [Abstract][Full Text] [Related]
14. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine. Karpf AR; Moore BC; Ririe TO; Jones DA Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of 5-Aza-2'-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A). Liu J; Xie YS; Wang FL; Zhang LJ; Zhang Y; Luo HS Biomed Pharmacother; 2013 Feb; 67(1):78-87. PubMed ID: 23201008 [TBL] [Abstract][Full Text] [Related]
16. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation. Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells. Kumagai T; Wakimoto N; Yin D; Gery S; Kawamata N; Takai N; Komatsu N; Chumakov A; Imai Y; Koeffler HP Int J Cancer; 2007 Aug; 121(3):656-65. PubMed ID: 17417771 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Bender CM; Pao MM; Jones PA Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064 [TBL] [Abstract][Full Text] [Related]
19. Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway. Lavelle D; DeSimone J; Hankewych M; Kousnetzova T; Chen YH Leuk Res; 2003 Nov; 27(11):999-1007. PubMed ID: 12859993 [TBL] [Abstract][Full Text] [Related]
20. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy. Jung Y; Park J; Kim TY; Park JH; Jong HS; Im SA; Robertson KD; Bang YJ; Kim TY J Mol Med (Berl); 2007 Oct; 85(10):1137-48. PubMed ID: 17571247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]